DE69415684D1 - Verfahren zur herstellung von mikrospharen mit einer wirbelschichtstufe - Google Patents

Verfahren zur herstellung von mikrospharen mit einer wirbelschichtstufe

Info

Publication number
DE69415684D1
DE69415684D1 DE69415684T DE69415684T DE69415684D1 DE 69415684 D1 DE69415684 D1 DE 69415684D1 DE 69415684 T DE69415684 T DE 69415684T DE 69415684 T DE69415684 T DE 69415684T DE 69415684 D1 DE69415684 D1 DE 69415684D1
Authority
DE
Germany
Prior art keywords
fluidized layer
producing microspheres
microspheres
producing
fluidized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69415684T
Other languages
English (en)
Other versions
DE69415684T2 (de
Inventor
Jeffrey Cleland
Andrew Jones
Michael Powell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69415684D1 publication Critical patent/DE69415684D1/de
Application granted granted Critical
Publication of DE69415684T2 publication Critical patent/DE69415684T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69415684T 1993-10-22 1994-10-13 Verfahren zur herstellung von mikrospharen mit einer wirbelschichtstufe Expired - Lifetime DE69415684T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14225793A 1993-10-22 1993-10-22
US14331393A 1993-10-25 1993-10-25
PCT/US1994/011678 WO1995011009A1 (en) 1993-10-22 1994-10-13 Method for preparing microspheres comprising a fluidized bed drying step

Publications (2)

Publication Number Publication Date
DE69415684D1 true DE69415684D1 (de) 1999-02-11
DE69415684T2 DE69415684T2 (de) 1999-06-10

Family

ID=26839915

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69415684T Expired - Lifetime DE69415684T2 (de) 1993-10-22 1994-10-13 Verfahren zur herstellung von mikrospharen mit einer wirbelschichtstufe

Country Status (9)

Country Link
EP (1) EP0724433B1 (de)
JP (1) JP3841309B2 (de)
AT (1) ATE175110T1 (de)
AU (1) AU8017494A (de)
CA (1) CA2172508C (de)
DE (1) DE69415684T2 (de)
DK (1) DK0724433T3 (de)
UY (1) UY23846A1 (de)
WO (1) WO1995011009A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ262634A (en) * 1993-02-23 1997-02-24 Genentech Inc Stabilizing polypeptides against degradation by organic solvents by admixing the peptide with trehalose or mannitol
CN1074923C (zh) 1993-11-19 2001-11-21 詹森药业有限公司 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
EP0765660A3 (de) * 1995-09-28 1998-09-23 Takeda Chemical Industries, Ltd. Mikrokapseln enthaltend 2-Piperazinon-1-essigsäure Verbindungen
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
EP0862419B2 (de) 1995-11-09 2010-11-17 Microbiological Research Authority Mikroverkapselte dna zur impfung und gentherapie
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
GB2310801A (en) * 1996-03-04 1997-09-10 Merck & Co Inc Process for removing an organic solvent from lactide-glycoside copolymer microspheres
US6190702B1 (en) 1996-03-28 2001-02-20 Takeda Chemical Industries, Ltd. Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase
MY118174A (en) * 1996-05-07 2004-09-30 Alkermes Inc Process for the preparation of microparticles
US6645495B1 (en) * 1997-08-29 2003-11-11 Antigenics, Inc. Compositions of saponin adjuvants and excipients
EP1028746B1 (de) 1997-11-07 2003-02-26 Chiron Corporation Verfahren zur herstellung von igf-i formulierungen mit verzögerter freisetzung
SE9801288D0 (sv) 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
GB9810236D0 (en) * 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
AU1226901A (en) * 1999-10-22 2001-05-08 Amgen, Inc. Biodegradable microparticles with novel erythropoietin stimulating protein
US20090104274A1 (en) * 2005-03-01 2009-04-23 Ajay Khopade Process of making microspheres
WO2015103447A1 (en) 2013-12-31 2015-07-09 Rapamycin Holdings, Llc Oral rapamycin nanoparticle preparations and use
RU2562263C9 (ru) * 2009-12-22 2016-04-27 Евоник Корпорейшн Способ и рабочий узел для приготовления микрочастиц с использованием эмульсии
UA111162C2 (uk) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
ES2642312T3 (es) * 2011-08-04 2017-11-16 Flexion Therapeutics, Inc. Corticosteroides para el tratamiento del dolor de articulaciones
EP3131546B1 (de) 2014-04-16 2022-02-16 Rapamycin Holdings, Inc. Orale rapamycinformulierung zur verwendung bei der behandlung von feliner chronischer gingivo-stomatitis (fcgs)
JPWO2023277051A1 (de) * 2021-06-30 2023-01-05

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IT1214629B (it) * 1985-08-29 1990-01-18 Formenti Farmaceutici Spa Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
IL84167A (en) * 1986-10-24 1991-04-15 Southern Res Inst Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
JP2813630B2 (ja) * 1987-02-20 1998-10-22 ジェネンテク，インコーポレイテッド ヒト免疫不全ウイルスのエンベロープポリペプチドおよびその抗体
DE3855869T2 (de) * 1987-02-20 1997-10-02 Genentech Inc Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern
NO176278C (no) * 1988-08-24 1995-03-08 Allied Colloids Ltd Fremgangsmåte for fremstilling av en partikkelformig blanding av aktiv bestanddel i et polymert materiale
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
FR2658432B1 (fr) * 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
AU8303691A (en) * 1991-04-24 1992-12-21 United States Of America, As Represented By The Secretary Of The Army, The Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
FR2703927B1 (fr) * 1993-04-13 1995-07-13 Coletica Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une polyamine pour former en milieu aqueux une membrane au moins en surface de particules gélifiées.
ES2182850T3 (es) * 1993-10-22 2003-03-16 Genentech Inc Procedimientos y composiciones para la microencapsulacion de adyuvantes.
AU7980794A (en) * 1993-10-22 1995-05-08 Genentech Inc. Methods and compositions for microencapsulation of antigens for use as vaccines

Also Published As

Publication number Publication date
CA2172508A1 (en) 1995-04-27
JPH09504026A (ja) 1997-04-22
AU8017494A (en) 1995-05-08
ATE175110T1 (de) 1999-01-15
JP3841309B2 (ja) 2006-11-01
DE69415684T2 (de) 1999-06-10
EP0724433B1 (de) 1998-12-30
EP0724433A1 (de) 1996-08-07
UY23846A1 (es) 1995-03-28
CA2172508C (en) 2005-08-23
DK0724433T3 (da) 1999-08-30
WO1995011009A1 (en) 1995-04-27

Similar Documents

Publication Publication Date Title
DE69415684T2 (de) Verfahren zur herstellung von mikrospharen mit einer wirbelschichtstufe
DE69205960T3 (de) Verfahren zur Herstellung von linearen Polyäthylenen mit niedriger Dichte.
DE68901889D1 (de) Verfahren zur herstellung von carnitin.
DE68902196D1 (de) Verfahren zur herstellung von befestigungselementen mit gewinde.
DE68908193D1 (de) Verfahren zur herstellung von fluorglimmer.
ATE162686T1 (de) Verfahren zur herstellung von getrockneten früchten
DE69225139D1 (de) Verfahren zur herstellung von starken diskontinuierlichen fibrillen
DE68901908D1 (de) Verfahren zur herstellung von mesophasepech.
DE68918601D1 (de) Verfahren zur herstellung von ortho-nitrobenzonitrilen.
DE68910388D1 (de) Strahlungshärtbare Zusammensetzung zur Herstellung einer abriebbeständigen antistatischen Schicht.
DE58902073D1 (de) Verfahren zur herstellung von organohalogensilanen.
DE68904436D1 (de) Verfahren zur herstellung von 1-alkyl-5-nitro-imidazolen.
DE68900640D1 (de) Verfahren zur herstellung von perfluorokohlenstoffpolymertraegern mit perfluorokohlenstoff-substituiertem gebundenem liganden oder binder.
DE58903458D1 (de) Verfahren zur herstellung von 1,5-dihydroxy- und 1,5 diaminonaphthalin.
ATA105992A (de) Verfahren zur herstellung von wasserlöslichen, trockenen leukoschwefelfarbstoffen
DE59207782D1 (de) Verfahren zur herstellung von 8,12-oxido-13,14,15,16-tetranorlabdan
DE68905908D1 (de) Verfahren zur herstellung von alkansulfonamiden.
DE69212821D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1-trifluorethan
DE68907180D1 (de) Verfahren zur herstellung von 2,3,5-trimethylbenzochinon.
DE69204039D1 (de) Verfahren zur Herstellung von gesättigten Kohlenwasserstoffen.
DE68905958D1 (de) Verfahren zur herstellung von urandioxid-pastillen.
DE58901624D1 (de) Verfahren zur herstellung von fluorbenzolen.
DE68906638D1 (de) Verfahren zur herstellung von 4-methylpyrazolen.
DE3887019D1 (de) Verfahren zur herstellung von zusammensetzungen mit anti-magengeschwür-wirkung.
DE68905103D1 (de) Verfahren zur herstellung von dihalogenobenzoldisulfonverbindungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition